BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28127199)

  • 1. Mitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesis.
    Gu JJ; Yao M; Yang J; Cai Y; Zheng WJ; Wang L; Yao DB; Yao DF
    World J Gastroenterol; 2017 Jan; 23(2):256-264. PubMed ID: 28127199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dynamic expression of carnitine palmitoyltransferase II in the mitochondrial inner membrane during hepatocyte malignant transformation induced by lipid accumulation].
    Gu JJ; Yao M; Cai Y; Fang M; Wang L; Zheng WJ; Yao DB; Dong ZZ; Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):279-284. PubMed ID: 28494547
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of Nrf2 and related factors on the progression of nonalcoholic steatohepatitis].
    Cai YQ; Zhang LZ; Wang DJ; Chen FM; Chen ZY; Zhu KY; Li JS; Yan MX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Sep; 30(5):465-70. PubMed ID: 25571645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
    Liu J; Han L; Zhu L; Yu Y
    Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Change in plasma nesfatin-1 concentration within high-fat diet induced nonalcoholic fatty liver disease rat models].
    Wu R; Chen Z; Xu Y; Ge J; Lü X
    Wei Sheng Yan Jiu; 2016 May; 45(3):452-7. PubMed ID: 27459811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal study of circulating miR-122 in a rat model of non-alcoholic fatty liver disease.
    Yamada H; Ohashi K; Suzuki K; Munetsuna E; Ando Y; Yamazaki M; Ishikawa H; Ichino N; Teradaira R; Hashimoto S
    Clin Chim Acta; 2015 Jun; 446():267-71. PubMed ID: 25958847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dysfunction in high-fat diet-induced nonalcoholic fatty liver disease: The alleviating effect and its mechanism of Polygonatum kingianum.
    Yang XX; Wang X; Shi TT; Dong JC; Li FJ; Zeng LX; Yang M; Gu W; Li JP; Yu J
    Biomed Pharmacother; 2019 Sep; 117():109083. PubMed ID: 31387169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yam Gruel alone and in combination with metformin regulates hepatic lipid metabolism disorders in a diabetic rat model by activating the AMPK/ACC/CPT-1 pathway.
    Dai Y; Qiu C; Zhang D; Li M; Liu W
    Lipids Health Dis; 2024 Jan; 23(1):28. PubMed ID: 38273354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial carnitine palmitoyltransferase-II dysfunction: A possible novel mechanism for nonalcoholic fatty liver disease in hepatocarcinogenesis.
    Yao M; Zhou P; Qin YY; Wang L; Yao DF
    World J Gastroenterol; 2023 Mar; 29(12):1765-1778. PubMed ID: 37032731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal expression of insulin-like growth factor-II and its dynamic quantitative analysis at different stages of hepatocellular carcinoma development.
    Qiu LW; Yao DF; Zong L; Lu YY; Huang H; Wu W; Wu XH
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):406-11. PubMed ID: 18693177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.
    Okada Y; Yamaguchi K; Nakajima T; Nishikawa T; Jo M; Mitsumoto Y; Kimura H; Nishimura T; Tochiki N; Yasui K; Mitsuyoshi H; Minami M; Kagawa K; Okanoue T; Itoh Y
    Liver Int; 2013 Feb; 33(2):301-11. PubMed ID: 23295058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure.
    Zaitone SA; Barakat BM; Bilasy SE; Fawzy MS; Abdelaziz EZ; Farag NE
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):587-600. PubMed ID: 25708949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease.
    Kathirvel E; Morgan K; French SW; Morgan TR
    Nutr Res; 2013 Nov; 33(11):932-41. PubMed ID: 24176233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preventive and therapeutic effects of compound ginkgo extract in rats with nonalcoholic steatohepatitis induced by high-fat, high-fructose diet].
    Yang Q; Zhao H; Zhou AZ; Lou ZH
    Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):852-858. PubMed ID: 27978932
    [No Abstract]   [Full Text] [Related]  

  • 15. Resistant Maltodextrin Ameliorates Altered Hepatic Lipid Homeostasis via Activation of AMP-Activated Protein Kinase in a High-Fat Diet-Fed Rat Model.
    Liu SH; Chiu CY; Huang LH; Chiang MT
    Nutrients; 2019 Jan; 11(2):. PubMed ID: 30699992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of JNK inhibitor XG-102 in a diet-induced rat model of non-alcoholic steatohepatitis].
    Hu Y; Peng N; Lei D; Cheng F; Chen Y
    Zhonghua Gan Zang Bing Za Zhi; 2014 Dec; 22(12):948-52. PubMed ID: 25654291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
    Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Female spontaneously diabetic Torii fatty rats develop nonalcoholic steatohepatitis-like hepatic lesions.
    Ishii Y; Motohashi Y; Muramatsu M; Katsuda Y; Miyajima K; Sasase T; Yamada T; Matsui T; Kume S; Ohta T
    World J Gastroenterol; 2015 Aug; 21(30):9067-78. PubMed ID: 26290633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wild ginseng cambial meristematic cells ameliorate hepatic steatosis and mitochondrial dysfunction in high-fat diet-fed mice.
    Lee SB; Cho HI; Jin YW; Lee EK; Ahn JY; Lee SM
    J Pharm Pharmacol; 2016 Jan; 68(1):119-27. PubMed ID: 26806698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of insulin-like growth factor-I receptor as a pertinent biomarker for hepatocytes malignant transformation.
    Yan XD; Yao M; Wang L; Zhang HJ; Yan MJ; Gu X; Shi Y; Chen J; Dong ZZ; Yao DF
    World J Gastroenterol; 2013 Sep; 19(36):6084-92. PubMed ID: 24106410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.